Antiretroviral therapy by De Clercq, Erik instant download

Antiretroviral therapy by De Clercq, Erik instant download

x, 359 pages : 26 cm, Includes bibliographical references and index, Kinetics of human immunodeficiency virus type 1 replication and therapy / Bharat Ramratnam and Martin H. Markowitz -- Cellular receptors as targets for anti-human immunodeficiency virus agents / Dominique Schols and Erik De Clercq -- Nucleoside and nucleotide reverse transcriptase inhibitors / J. Balzarini and E. De Clercq -- Nonnucleoside reverse transcriptase inhibitors / J. Balzarini, R. Esnouf, and E. De Clercq -- Human immunodeficiency virus type 1 integrase-targeted inhibitor design / Nouri Neamati [and others] -- Inhibitors of transcription and transactivation as anti-human immunodeficiency virus agents / Jonathan Karn -- Oligonucleotides as antiretroviral agents / A. Kirk Field -- Protease inhibitors as anti-human immunodeficiency virus agents / Dale J. Kempf, Akhteruzzaman Molla, and Ann Hsu -- Glycoprotein-processing enzymes as a target for human immunodeficiency virus chemotherapy / A. Stanley Tyms -- Cellular factors as targets for anti-human immunodeficiency virus therapy / Masanori Baba -- Therapeutic human immunodeficiency virus vaccines : concept, current status, and future directions / John S. Lambert, Robert R. Redfield, and Edmund C. Tramont -- Clinical usefulness of human immunodeficiency virus drug resistance monitoring / Anne-Mieke Vandamme and Erik De Clercq -- Emergence of drug-resistant human immunodeficiency virus type 1 (HIV-1) variants and their impact on antiretroviral therapy of HIV-1 infection / Mark F. Kavlick and Hiroaki Mitsuya -- Combination antiretroviral therapy / Cécile Tremblay, Joan C. Kaplan, and Martin S. Hirsch -- Drug-drug interactions in human immunodeficiency virus infection / Charles W. Flexner and Stephen C. Piscitelli, Kinetics of human immunodeficiency virus type 1 replication and therapy / Bharat Ramratnam and Martin H. Markowitz -- Cellular receptors as targets for anti-human immunodeficiency virus agents / Dominique Schols and Erik De Clercq --